Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Stage Trial of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Metastatic Melanoma

NCT00084214 is registered in ClinicalTrials.gov with Synta Pharmaceuticals Corp. as lead sponsor.

NCT NCT00084214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00084214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Stage Trial of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Metastatic Melanoma
Lead sponsor
Synta Pharmaceuticals Corp.
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2004
Completion date
Not reported
Enrollment
103
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma